Abstract
The aim of this study was to characterize the phenotype and treatment of young patients (manifestation <30 years) with diabetes of mitochondrial origin (DMO), based on the German/Austrian DPV (Diabetes Patienten Verlaufsdokumentation) registry. Only 13 (0.02 %) of all patients with diabetes in this cohort were identified with DMO, mainly due to the Kearns-Sayre (n = 5), Pearson (n = 3), or mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome (n = 2). The onset of DMO (14.2, interquartile range (IQR) 7.1–16 years) was later than diabetes onset in individuals with T1D but earlier than in T2D. At manifestation, patients exhibited a mild elevation of blood glucose concentrations (251, IQR 178–299 mg/dl) without ketoacidosis. They had lower body mass index (BMI) values (−1.39 ± 0.28 kg/m2) than peers with T1D or T2D (p < 0.0001) and higher triglycerides (211, IQR 134–574 mg/dl) than in T1D (p = 0.04) while there was a high rate of dyslipidemia (86 %). Insulin requirements (0.58, IQR 0.37–0.90 U/kg/d) were between T1D and T2D while glucometabolic control (glycated hemoglobin A1c (HbA1c) 7.4 ± 0.52 %) in DMO was comparable to age-matched T2D and stable over a 5-year follow-up.
Conclusion: Primary mitochondrial disorders are a rare cause of juvenile diabetes and likely to be underdiagnosed. As there is clinical overlap with T1D and T2D, dyslipidemia and low body weight may help to identify further DMO cases.
What is Known: • In adults diabetes of mitochondrial origin (DMO) is a rare cause of non-autoimmune diabetes, affecting about 0.8 % of diabetes cases. • Common features are a maternal family history of diabetes, hearing loss and neurological abnormalities. |
What is New: • In our juvenile cohort 0.02 % of diabetes patients (age < 30 years) were affected by DMO, while Kearns Sayre, MELAS and Pearson syndrome were the most frequent entities. • Juvenile DMO patients exhibited dyslipidemia, higher triglycerides and a lower BMI than peers with T1D or T2D, while some patients also showed retinal changes. |
Similar content being viewed by others
Abbreviations
- DMO:
-
Diabetes of mitochondrial origin
- DPV:
-
Diabetes Patienten Verlaufsdokumentation
- HbA1c:
-
Glycated hemoglobin A1c
- IQR:
-
Interquartile range
- KSS:
-
Kearns-Sayre syndrome
- MELAS:
-
Syndrome mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes
- MIDD:
-
Maternally inherited diabetes and deafness
- T1D:
-
Type 1 diabetes mellitus
- T2D:
-
Type 2 diabetes mellitus
- SD:
-
Standard deviation
References
Abad MM, Cotter PD, Fodor FH, Larson S, Ginsberg-Fellner F, Desnick RJ (1997) Screening for the mitochondrial DNA A3243G mutation in children with insulin-dependent diabetes mellitus. Metabolism 46:445–449
Blake R, Trounce IA (2014) Mitochondrial dysfunction and complications associated with diabetes. Biochim Biophys Acta 1840(4):1404–12
Donaghue KC, Wadwa RP, Dimeglio LA, Wong TY, Chiarelli F, Marcovecchio ML, Salem M, Raza J, Hofman PL, Craig ME (2014) Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes 15(S20):257–269
Finsterer J, Segall L (2010) Drugs interfering with mitochondrial disorders. Drug Chem Toxicol 33(2):138–151
Frenzel CB, Das AM, Marg W (2001) Mitochondriopathie bei einem Kind mit Shwachman-Syndrom und Zöliakie. Monatsschr Kinderheilkd 149:377–381
Gerbitz KD, van den Ouweland JM, Maassen JA, Jaksch M (1995) Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1271(1):253–260
Gerstl EM, Rabl W, Rosenbauer J, Gröbe H, Hofer SE, Krause U, Holl RW (2008) Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27.035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 167(4):447–453
Goli AK, Goli SA, Byrd RP Jr, Roy TM (2002) Simvastatin-induced lactic acidosis: a rare adverse reaction? Clin Pharmacol Ther 72(4):461–464
Guillausseau PJ, Dubois-Laforgue D, Massin P, Laloi-Michelin M, Bellanné-Chantelot C, Gin H, Bertin E, Blickle JF, Bauduceau B, Bouhanick B, Cahen-Varsaux J, Casanova S, Charpentier G, Chedin P, Derrien C, Grimaldi A, Guerci B, Kaloustian E, Lorenzini F, Murat A, Olivier F, Paques M, Paquis-Flucklinger V, Tielmans A, Vincenot M, Vialettes B, Timsit J, GEDIAM, Mitochondrial Diabetes French Study Group (2004) Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD). Diabetes Metab 30(2):181–186
Guillausseau PJ, Massin P, Dubois-LaForgue D, Timsit J, Virally M, Gin H, Bertin E, Blickle JF, Bouhanick B, Cahen J, Caillat-Zucman S, Charpentier G, Chedin P, Derrien C, Ducluzeau PH, Grimaldi A, Guerci B, Kaloustian E, Murat A, Olivier F, Paques M, Paquis-Flucklinger V, Porokhov B, Samuel-Lajeunesse J, Vialettes B (2001) Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 134(9 Pt 1):721–728
Ho J, Pacaud D, Rakic M, Khan A (2014) Diabetes in pediatric patients with Kearns-Sayre syndrome: clinical presentation of 2 cases and a review of pathophysiology. Can J Diabetes 38(4):225–228
Holl RW, Karges B, Rosenbauer J, Meissner T, Kapellen T, Icks A, Schober E (2013) Häufige und seltene diabetesformen in der pädiatrischen Diabetologie: Ergebnisse des DPV-Registers im BMBF-Kompetenznetz Diabetes. Diabetes Stoffwechsel Herz 22:42
Hosszúfalusi N, Karcagi V, Horváth R, Palik E, Várkonyi J, Rajczy K, Prohászka Z, Szentirmai C, Karádi I, Romics L, Pánczél P (2009) A detailed investigation of maternally inherited diabetes and deafness (MIDD) including clinical characteristics, C-peptide secretion, HLA-DR and -DQ status and autoantibody pattern. Diabetes Metab Res Rev 25(2):127–135
Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y, Hayakawa T, Matsuoka R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, Yazaki Y (1994) A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330(14):962–968
Karaa A, Goldstein A (2015) The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes. Pediatr Diabetes 16(1):1–9
Kishimoto M, Hashiramoto M, Araki S, Ishida Y, Kazumi T, Kanda E, Kasuga M (1995) Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene. Diabetologia 38(2):193–200
Koenig MK (2008) Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol 38(5):305–313
Kromeyer-Hauschild K, Wabitsch M, Geller F, Ziegler A, Geiß HC, Hesse V, Hippel V, Jaeger U, Johnsen D, Kiess W, Korte W, Kunze D, Menner K, Müller M, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Hebebrand J (2001) Perzentile für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatschr Kinderheilkd 149(8):807–818
Laloi-Michelin M, Meas T, Ambonville C, Bellanné-Chantelot C, Beaufils S, Massin P, Vialettes B, Gin H, Timsit J, Bauduceau B, Bernard L, Bertin E, Blickle JF, Cahen-Varsaux J, Cailleba A, Casanova S, Cathebras P, Charpentier G, Chedin P, Crea T, Delemer B, Dubois-Laforgue D, Duchemin F, Ducluzeau PH, Bouhanick B, Dusselier L, Gabreau T, Grimaldi A, Guerci B, Jacquin V, Kaloustian E, Larger E, Lecleire-Collet A, Lorenzini F, Louis J, Mausset J, Murat A, Nadler-Fluteau S, Olivier F, Paquis-Flucklinger V, Paris-Bockel D, Raynaud I, Reznik Y, Riveline JP, Schneebeli S, Sonnet E, Sola-Gazagnes A, Thomas JL, Trabulsi B, Virally M, Guillausseau PJ, Mitochondrial Diabetes French Study Group (2009) The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab 94(8):3025–3030
Laloi-Michelin M, Virally M, Jardel C, Meas T, Ingster-Moati I, Lombès A, Massin P, Chabriat H, Tielmans A, Mikol J, Guillausseau PJ (2006) Kearns Sayre syndrome: an unusual form of mitochondrial diabetes. Diabetes Metab 32(2):182–186
Liou CW, Huang CC, Lin TK, Tsai JL, Wei YH (2000) Correction of pancreatic beta-cell dysfunction with coenzyme Q(10) in a patient with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome and diabetes mellitus. Eur Neurol 43(1):54–55
Maassen JA, ‘T Hart LM, Van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS, Raap AK, Janssen GM, Lemkes HH (2004) Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53:S103–S109
Marín-García J, Goldenthal MJ, Flores-Sarnat L, Sarnat HB (2002) Severe mitochondrial cytopathy with complete A-V block, PEO, and mtDNA deletions. Pediatr Neurol 27(3):213–216
Mazzaccara C, Iafusco D, Liguori R, Ferrigno M, Galderisi A, Vitale D, Simonelli F, Landolfo P, Prisco F, Masullo M, Sacchetti L (2012) Mitochondrial diabetes in children: seek and you will find it. PLoS One 7(4):e34956
Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H, Cystic Fibrosis Related Diabetes Therapy Study Group (2009) Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 32(10):1783–1788
Murphy R, Turnbull DM, Walker M, Hattersley AT (2008) Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A > G mitochondrial point mutation. Diabet Med 25(4):383–399
Naing A, Kenchaiah M, Krishnan B, Mir F, Charnley A, Egan C, Bano G (2014) Maternally inherited diabetes and deafness (MIDD): diagnosis and management. J Diabetes Complicat 28(4):542–546
Neustadt J, Pieczenik SR (2008) Medication-induced mitochondrial damage and disease. Mol Nutr Food Res 52(7):780–788
Olsson C, Zethelius B, Lagerström-Fermér M, Asplund J, Berne C, Landegren U (1998) Level of heteroplasmy for the mitochondrial mutation A3243G correlates with age at onset of diabetes and deafness. Hum Mutat 12(1):52–58
Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348(3):607–614
Rewers MJ, Pillay K, Craig ME, Hanas R, Acerini CL, Maahs DM, International Society for Pediatric and Adolescent Diabetes (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 15(S20):102–114
Saneto RP, Sedensky MM (2013) Mitochondrial disease in childhood: mtDNA encoded. Neurotherapeutics 10(2):199–211
Schaefer AM, Walker M, Turnbull DM, Taylor RW (2013) Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol 379(1-2):2–11
Silvestre-Aillaud P, BenDahan D, Paquis-Fluckinger V, Pouget J, Pelissier JF, Desnuelle C, Cozzone PJ, Vialettes B (1995) Could coenzyme Q10 and L-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA? Diabetologia 38(12):1485–1486
Stark R, Roden M (2007) ESCI Award 2006. Mitochondrial function and endocrine diseases. Eur J Clin Investig 37(4):236–248
Suzuki S, Hinokio Y, Ohtomo M, Hirai M, Hirai A, Chiba M, Kasuga S, Satoh Y, Akai H, Toyota T (1998) The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 41(5):584–588
Szendroedi J, Schmid AI, Meyerspeer M, Cervin C, Kacerovsky M, Smekal G, Gräser-Lang S, Groop L, Roden M (2009) Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care 32(4):677–679
Takeshima T, Nakashima K (2005) MIDD and MELAS: a clinical spectrum. Intern Med 44(4):276–277
Tang X, Luo YX, Chen HZ, Liu DP (2014) Mitochondria, endothelial cell function, and vascular diseases. Front Physiol 5:175
Turner N, Heilbronn LK (2008) Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab 19(9):324–330
van Essen EH, Roep BO, ‘t Hart LM, Jansen JJ, Van den Ouweland JM, Lemkes HH, Maassen JA (2000) HLA-DQ polymorphism and degree of heteroplasmy of the A3243G mitochondrial DNA mutation in maternally inherited diabetes and deafness. Diabet Med 17(12):841–847
Velho G, Byrne MM, Clément K, Sturis J, Pueyo ME, Blanché H, Vionnet N, Fiet J, Passa P, Robert JJ, Polonsky KS, Froguel P (1996) Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes 45(4):478–487
Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM (2007) Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 50(10):2085–2089
Authors’ contributions
CR, TM and RWH wrote the manuscript. EB and RWH performed statistical analysis. AT, PMH, HH, EB, WM clinically managed the patients and critically reviewed the manuscript together with MR and EB. All the authors approved the final copy of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The DPV has the ethical approval at the University of Ulm. Data collection was approved by the local institutional review boards.
Funding
The DPV database is supported by the German Federal Ministry of Education and Research (BMBF) as part of the Competence Network for Diabetes mellitus (Kompetenznetz Diabetes mellitus, FKZ 01GI1106), which was integrated into the German Center for Diabetes Research (DZD) in 2015, the German Diabetes Association (Deutsche Diabetes Gesellschaft, DDG), the European Foundation for the Study of Diabetes (EFSD), and the Heinz Bürger-Büsing Foundation.
Conflict of interest
The authors declare that they have no competing interests.
The DPV initiative received grant support from Sanofi Aventis, Lilly, Novo Nordisk, Boehringer Ingelheim, Roche Diagnostics and Medtronic. None of these grants is related to the present study.
Additional information
Communicated by Beat Steinmann
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 34 kb)
Rights and permissions
About this article
Cite this article
Reinauer, C., Meissner, T., Roden, M. et al. Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry. Eur J Pediatr 175, 613–622 (2016). https://doi.org/10.1007/s00431-015-2675-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-015-2675-5